Logan Kelley-Baker

Statistics

Publications

Citations

179

H-Index

Active since

2015

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Logan Kelley-Baker is an author at Center for Drug Evaluation and Research specializing in life sciences, innate immune activation, and innate immunity.

ORCID

Publications per year

2015–2022

Publications

Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins

Lydia Haile, Montserrat Puig, Logan Kelley-Baker et al. · PLoS ONE · 2015 · 72 citations · Full text

Life Sciences, Immunology, Pharmaceutical Biotechnology +17

Long-term persistence of infectious Zika virus: Inflammation and behavioral sequela in mice

Derek D.C. Ireland, Mohanraj Manangeeswaran, Aaron P. Lewkowicz et al. · PLoS Pathogens · 2020 · 52 citations · Full text

Life Sciences, Infectious Diseases, Neurology +17

Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta

Lydia Haile, Swamy K. Polumuri, Roshni Rao et al. · Scientific Reports · 2017 · 29 citations · Full text

Life Sciences, Immunology, Inflammation +16

Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients

Seth G. Thacker, Cheng Her, Logan Kelley-Baker et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model

Hana Lee, Ian L. McWilliams, Aaron P. Lewkowicz et al. · Emerging Microbes & Infections · 2021 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–5 of 5